A new study has found that the risk of serious bleeding is similar when taking the blood thinners apixaban and dabigatran compared to aspirin. However, the blood thinner rivaroxaban has a higher ...
A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...
Major bleeding was low overall, but the findings align with other large datasets showing greater risk with rivaroxaban.
GlobalData on MSN3d
Taho Pharma’s apixaban oral strips equivalent to Eliquis in pivotal trialTaho Pharmaceuticals’s apixaban-based oral dissolving strips were discovered to be a bioequivalent of Pfizer and ...
In a systematic review and meta-analysis of trials of non-vitamin K oral anticoagulants vs. single antiplatelet therapy, ...
Apixaban significantly reduces stroke risk in people with subclinical atrial fibrillation and prior stroke history.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback